Treatment selection in patients with relapsed or refractory follicular lymphoma

Clin Adv Hematol Oncol. 2020 Dec;18 Suppl 20(12):11-14.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Lymphoma, Follicular* / diagnosis
  • Lymphoma, Follicular* / drug therapy
  • Recurrence
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Rituximab